Merits of hiPSC-Derived Cardiomyocytes for In Vitro Research and Testing Drug Toxicity

Merits of hiPSC-Derived Cardiomyocytes for In Vitro Research and Testing Drug Toxicity

The progress of medical technology and scientific advances in the field of anticancer treatment have increased the survival probabilities and duration of life of patients. However, cancer-therapy-induced cardiac dysfunction remains a clinically salient problem. Effective anticancer therapies may eve...

Full description

Bibliographic Details
Main Authors:	Ping-Hsien Wang, Yi-Hsien Fang, Yen-Wen Liu, Min-Long Yeh
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Biomedicines
Subjects:	cardiotoxicity human-induced pluripotent stem cell (hiPSC) cardiomyocyte (CM) cardiac differentiation H9c2 hepatocellular carcinoma (HCC)
Online Access:	https://www.mdpi.com/2227-9059/10/11/2764

Similar Items

Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery
by: Keyang Zhu, et al.
Published: (2023-01-01)

Optical Mapping in hiPSC-CM and Zebrafish to Resolve Cardiac Arrhythmias
by: Bert Vandendriessche, et al.
Published: (2020-12-01)

An in silico hiPSC-Derived Cardiomyocyte Model Built With Genetic Algorithm
by: Akwasi D. Akwaboah, et al.
Published: (2021-06-01)

Expression of Extracellular Vesicle PIWI-Interacting RNAs Throughout hiPSC-Cardiomyocyte Differentiation
by: Ana F. Louro, et al.
Published: (2022-06-01)

Does Enhanced Structural Maturity of hiPSC-Cardiomyocytes Better for the Detection of Drug-Induced Cardiotoxicity?
by: Dieter Van de Sande, et al.
Published: (2023-04-01)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates
by: Suzan J. G. Knottnerus, et al.
Published: (2020-04-01)

hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
by: Junjun Li, et al.
Published: (2020-11-01)

The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential
by: Minki Hwang, et al.
Published: (2023-03-01)

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products
by: Liam Simms, et al.
Published: (2022-02-01)

SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts
by: Xiao Li, et al.
Published: (2023-12-01)

From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies
by: Martina Rabino, et al.
Published: (2023-07-01)

Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
by: Tromondae K. Feaster, et al.
Published: (2021-11-01)

Integrated Manufacturing of Suspended and Aligned Nanofibrous Scaffold for Structural Maturation and Synchronous Contraction of HiPSC-Derived Cardiomyocytes
by: Lingling Liu, et al.
Published: (2023-06-01)

Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
by: C. Altrocchi, et al.
Published: (2023-07-01)

Toward a Microencapsulated 3D hiPSC-Derived in vitro Cardiac Microtissue for Recapitulation of Human Heart Microenvironment Features
by: Bernardo Abecasis, et al.
Published: (2020-11-01)

Fluorescence Spectroscopy of Low-Level Endogenous β-Adrenergic Receptor Expression at the Plasma Membrane of Differentiating Human iPSC-Derived Cardiomyocytes
by: Philipp Gmach, et al.
Published: (2022-09-01)

Activation of AMPK Promotes Maturation of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
by: Liang Ye, et al.
Published: (2021-03-01)

Hydrogel‐Sheathed hiPSC‐Derived Heart Microtissue Enables Anchor‐Free Contractile Force Measurement
by: Yuta Kurashina, et al.
Published: (2023-12-01)

hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation
by: Cláudia C. Miranda, et al.
Published: (2020-07-01)

Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
by: Yoshikazu Kishino, et al.
Published: (2023-03-01)

One Billion hiPSC-Cardiomyocytes: Upscaling Engineered Cardiac Tissues to Create High Cell Density Therapies for Clinical Translation in Heart Regeneration
by: Kiera D. Dwyer, et al.
Published: (2023-05-01)

Reliability of human retina organoid generation from hiPSC-derived neuroepithelial cysts
by: Madalena Carido, et al.
Published: (2023-10-01)

Isogenic hiPSC-derived liver-on-chip platforms: A valuable tool for modeling metabolic liver diseases
by: Kehinde Oluwasegun Aina
Published: (2023-12-01)

A novel and cost-effective method for high-throughput 3D culturing and rhythmic assessment of hiPSC-derived cardiomyocytes using retroreflective Janus microparticles
by: Huyen T. M. Pham, et al.
Published: (2023-08-01)

Characterization of cytoskeleton features and maturation status of cultured human iPSC-derived cardiomyocytes
by: Christian Zuppinger, et al.
Published: (2017-06-01)

Replacement of Mouse Microglia With Human Induced Pluripotent Stem Cell (hiPSC)-Derived Microglia in Mouse Organotypic Slice Cultures
by: Ari Ogaki, et al.
Published: (2022-07-01)

hiPSC-derived GRN-deficient astrocytes delay spiking activity of developing neurons
by: Christopher Lee, et al.
Published: (2023-06-01)

Preclinical Large Animal Porcine Models for Cardiac Regeneration and Its Clinical Translation: Role of hiPSC-Derived Cardiomyocytes
by: Divya Sridharan, et al.
Published: (2023-04-01)

Modeling Movement Disorders via Generation of hiPSC-Derived Motor Neurons
by: Masuma Akter, et al.
Published: (2022-11-01)

Challenges in Physiological Phenotyping of hiPSC-Derived Neurons: From 2D Cultures to 3D Brain Organoids
by: Pedro Mateos-Aparicio, et al.
Published: (2020-08-01)

Incomplete Assembly of the Dystrophin-Associated Protein Complex in 2D and 3D-Cultured Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Guillaume Gilbert, et al.
Published: (2021-11-01)

Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy
by: Wei Zheng, et al.
Published: (2018-08-01)

Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation
by: Francesco Lodola, et al.
Published: (2021-07-01)

Human induced pluripotent stem cell-derived cardiomyocytes as an electrophysiological model: Opportunities and challenges—The Hamburg perspective
by: Djemail Ismaili, et al.
Published: (2023-02-01)

hiPSC-Derived Schwann Cells Influence Myogenic Differentiation in Neuromuscular Cocultures
by: Sarah Janice Hörner, et al.
Published: (2021-11-01)

Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes
by: Lu Cao, et al.
Published: (2020-05-01)

Regulation of APD and Force by the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Human-Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue
by: Djemail Ismaili, et al.
Published: (2022-08-01)

Mechanisms of hyperexcitability in Alzheimer’s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls
by: Swagata Ghatak, et al.
Published: (2019-11-01)

Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Goekhan Yuecel, et al.
Published: (2023-09-01)

Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin
by: Paulina Koczurkiewicz-Adamczyk, et al.
Published: (2021-06-01)